Commerce secretary urges pharma industry to achieve 90% domestic raw material supply
India’s pharmaceutical industry, a global supplier of affordable medicines, faces challenges due to heavy reliance on imported raw materials. At a recent industry event, Commerce Secretary Rajesh Agrawal called for greater self-reliance to ensure resilience against global disruptions.
Key Points From The Address
- Domestic Production: Agrawal urged the sector to meet 80–90% of raw material needs locally.
- Resilient Supply Chains: Emphasized insulating supply chains from geopolitical risks.
- Market Diversification: Highlighted the need to expand exports beyond current markets.
- Innovation Focus: Encouraged moving towards a value-driven, innovation-led industry.
Why This Matters
- India exports medicines to nearly 200 countries, but supply chain vulnerabilities remain.
- Global uncertainties, including trade disruptions, highlight the need for domestic capacity.
- Strengthening local production will reduce dependence on imports and enhance India’s global competitiveness.
Key Highlights
• Commerce Secretary Rajesh Agrawal calls for 80–90% domestic raw material production
• Addressed Chintan Shivir 2026 organized by Pharmexcil
• Stressed resilient supply chains and market diversification
• India exports medicines to nearly 200 countries
• Focus on innovation and value-driven growth in pharma sector
Sources: The Economic Times, BW Businessworld, The Week
Stay Ahead – Explore Now! Adobe India — UX design, AI and creative cloud engineering roles for experienced tech professionals.






